27th Annual South Miami Hospital Harry Kapp Symposium Evaluation

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	0
The information and/or skills learned will enhance my professional competence or ability.	The information and/or skills learned will enhance my professional competence or ability. - 5	The information and/or skills learned will enhance my professional competence or ability. - 4	The information and/or skills learned will enhance my professional competence or ability. - 3	The information and/or skills learned will enhance my professional competence or ability. - 2	The information and/or skills learned will enhance my professional competence or ability. - 1	The information and/or skills learned will enhance my professional competence or ability. - 0
This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients.	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 5	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 4	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 3	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 2	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 1	This activity conveyed information which will assist me in improving the health and/or treatment outcomes of of my patients. - 0

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree NA=Not applicable to my practice

	5	4	3	2	1	NA
Discuss some of the latest research on acute respiratory distress syndrome (ARDS)	Discuss some of the latest research on acute respiratory distress syndrome (ARDS) - 5	Discuss some of the latest research on acute respiratory distress syndrome (ARDS) - 4	Discuss some of the latest research on acute respiratory distress syndrome (ARDS) - 3	Discuss some of the latest research on acute respiratory distress syndrome (ARDS) - 2	Discuss some of the latest research on acute respiratory distress syndrome (ARDS) - 1	Discuss some of the latest research on acute respiratory distress syndrome (ARDS) - NA
Implement evidence-based strategies in the treatment of patients with ARDS to improve patient outcomes.	Implement evidence-based strategies in the treatment of patients with ARDS to improve patient outcomes. - 5	Implement evidence-based strategies in the treatment of patients with ARDS to improve patient outcomes. - 4	Implement evidence-based strategies in the treatment of patients with ARDS to improve patient outcomes. - 3	Implement evidence-based strategies in the treatment of patients with ARDS to improve patient outcomes. - 2	Implement evidence-based strategies in the treatment of patients with ARDS to improve patient outcomes. - 1	Implement evidence-based strategies in the treatment of patients with ARDS to improve patient outcomes. - NA
Asses the effectiveness of endoscopic lung volume reduction (ELVR) in patients with advanced emphysema.	Asses the effectiveness of endoscopic lung volume reduction (ELVR) in patients with advanced emphysema. - 5	Asses the effectiveness of endoscopic lung volume reduction (ELVR) in patients with advanced emphysema. - 4	Asses the effectiveness of endoscopic lung volume reduction (ELVR) in patients with advanced emphysema. - 3	Asses the effectiveness of endoscopic lung volume reduction (ELVR) in patients with advanced emphysema. - 2	Asses the effectiveness of endoscopic lung volume reduction (ELVR) in patients with advanced emphysema. - 1	Asses the effectiveness of endoscopic lung volume reduction (ELVR) in patients with advanced emphysema. - NA
Effectively identify patients that will benefit from ELVR to manage severe COPD.	Effectively identify patients that will benefit from ELVR to manage severe COPD. - 5	Effectively identify patients that will benefit from ELVR to manage severe COPD. - 4	Effectively identify patients that will benefit from ELVR to manage severe COPD. - 3	Effectively identify patients that will benefit from ELVR to manage severe COPD. - 2	Effectively identify patients that will benefit from ELVR to manage severe COPD. - 1	Effectively identify patients that will benefit from ELVR to manage severe COPD. - NA
Identify patient’s failure that would benefit from ECMO support.	Identify patient’s failure that would benefit from ECMO support. - 5	Identify patient’s failure that would benefit from ECMO support. - 4	Identify patient’s failure that would benefit from ECMO support. - 3	Identify patient’s failure that would benefit from ECMO support. - 2	Identify patient’s failure that would benefit from ECMO support. - 1	Identify patient’s failure that would benefit from ECMO support. - NA
Recognize the importance timing in referral, transportation and cannulation in the management of ECMO.	Recognize the importance timing in referral, transportation and cannulation in the management of ECMO. - 5	Recognize the importance timing in referral, transportation and cannulation in the management of ECMO. - 4	Recognize the importance timing in referral, transportation and cannulation in the management of ECMO. - 3	Recognize the importance timing in referral, transportation and cannulation in the management of ECMO. - 2	Recognize the importance timing in referral, transportation and cannulation in the management of ECMO. - 1	Recognize the importance timing in referral, transportation and cannulation in the management of ECMO. - NA
Asses potential complications and outcomes of ECMO support for respiratory failure.	Asses potential complications and outcomes of ECMO support for respiratory failure. - 5	Asses potential complications and outcomes of ECMO support for respiratory failure. - 4	Asses potential complications and outcomes of ECMO support for respiratory failure. - 3	Asses potential complications and outcomes of ECMO support for respiratory failure. - 2	Asses potential complications and outcomes of ECMO support for respiratory failure. - 1	Asses potential complications and outcomes of ECMO support for respiratory failure. - NA
Assess indications and contraindications for lung transplant.	Assess indications and contraindications for lung transplant. - 5	Assess indications and contraindications for lung transplant. - 4	Assess indications and contraindications for lung transplant. - 3	Assess indications and contraindications for lung transplant. - 2	Assess indications and contraindications for lung transplant. - 1	Assess indications and contraindications for lung transplant. - NA
Distinguish factors that influence the rank of the patient on lung transplant waitlist.	Distinguish factors that influence the rank of the patient on lung transplant waitlist. - 5	Distinguish factors that influence the rank of the patient on lung transplant waitlist. - 4	Distinguish factors that influence the rank of the patient on lung transplant waitlist. - 3	Distinguish factors that influence the rank of the patient on lung transplant waitlist. - 2	Distinguish factors that influence the rank of the patient on lung transplant waitlist. - 1	Distinguish factors that influence the rank of the patient on lung transplant waitlist. - NA
Review epidemiology of nontuberculous mycobacterial (NTM) and assess clinical presentation of pulmonary and extra-pulmonary NTM.	Review epidemiology of nontuberculous mycobacterial (NTM) and assess clinical presentation of pulmonary and extra-pulmonary NTM. - 5	Review epidemiology of nontuberculous mycobacterial (NTM) and assess clinical presentation of pulmonary and extra-pulmonary NTM. - 4	Review epidemiology of nontuberculous mycobacterial (NTM) and assess clinical presentation of pulmonary and extra-pulmonary NTM. - 3	Review epidemiology of nontuberculous mycobacterial (NTM) and assess clinical presentation of pulmonary and extra-pulmonary NTM. - 2	Review epidemiology of nontuberculous mycobacterial (NTM) and assess clinical presentation of pulmonary and extra-pulmonary NTM. - 1	Review epidemiology of nontuberculous mycobacterial (NTM) and assess clinical presentation of pulmonary and extra-pulmonary NTM. - NA
Effectively evaluate diagnostic approaches of NTM and treatment options to improve patient outcomes.	Effectively evaluate diagnostic approaches of NTM and treatment options to improve patient outcomes. - 5	Effectively evaluate diagnostic approaches of NTM and treatment options to improve patient outcomes. - 4	Effectively evaluate diagnostic approaches of NTM and treatment options to improve patient outcomes. - 3	Effectively evaluate diagnostic approaches of NTM and treatment options to improve patient outcomes. - 2	Effectively evaluate diagnostic approaches of NTM and treatment options to improve patient outcomes. - 1	Effectively evaluate diagnostic approaches of NTM and treatment options to improve patient outcomes. - NA
Discuss the epidemiology of sarcoidosis.	Discuss the epidemiology of sarcoidosis. - 5	Discuss the epidemiology of sarcoidosis. - 4	Discuss the epidemiology of sarcoidosis. - 3	Discuss the epidemiology of sarcoidosis. - 2	Discuss the epidemiology of sarcoidosis. - 1	Discuss the epidemiology of sarcoidosis. - NA
Assess the clinical presentation of pulmonary and extra-pulmonary sarcoidosis.	Assess the clinical presentation of pulmonary and extra-pulmonary sarcoidosis. - 5	Assess the clinical presentation of pulmonary and extra-pulmonary sarcoidosis. - 4	Assess the clinical presentation of pulmonary and extra-pulmonary sarcoidosis. - 3	Assess the clinical presentation of pulmonary and extra-pulmonary sarcoidosis. - 2	Assess the clinical presentation of pulmonary and extra-pulmonary sarcoidosis. - 1	Assess the clinical presentation of pulmonary and extra-pulmonary sarcoidosis. - NA
Define diagnostic approach and treatment options.	Define diagnostic approach and treatment options. - 5	Define diagnostic approach and treatment options. - 4	Define diagnostic approach and treatment options. - 3	Define diagnostic approach and treatment options. - 2	Define diagnostic approach and treatment options. - 1	Define diagnostic approach and treatment options. - NA

Rate the following *

Scoring Key: 5=Excellent 4=Very Good 3=Good 2=Fair 1=Poor

	5	4	3	2	1
Course content.	Course content. - 5	Course content. - 4	Course content. - 3	Course content. - 2	Course content. - 1
Rabih Bechara, M.D., FCCP	Rabih Bechara, M.D., FCCP - 5	Rabih Bechara, M.D., FCCP - 4	Rabih Bechara, M.D., FCCP - 3	Rabih Bechara, M.D., FCCP - 2	Rabih Bechara, M.D., FCCP - 1
Sajive Aleyas M.D.	Sajive Aleyas M.D. - 5	Sajive Aleyas M.D. - 4	Sajive Aleyas M.D. - 3	Sajive Aleyas M.D. - 2	Sajive Aleyas M.D. - 1
Hassan M. Alnuaimat, M.D.	Hassan M. Alnuaimat, M.D. - 5	Hassan M. Alnuaimat, M.D. - 4	Hassan M. Alnuaimat, M.D. - 3	Hassan M. Alnuaimat, M.D. - 2	Hassan M. Alnuaimat, M.D. - 1
Neeraj Sinha, M.D.	Neeraj Sinha, M.D. - 5	Neeraj Sinha, M.D. - 4	Neeraj Sinha, M.D. - 3	Neeraj Sinha, M.D. - 2	Neeraj Sinha, M.D. - 1
Mehdi Mirsaeidi, M.D., MPH	Mehdi Mirsaeidi, M.D., MPH - 5	Mehdi Mirsaeidi, M.D., MPH - 4	Mehdi Mirsaeidi, M.D., MPH - 3	Mehdi Mirsaeidi, M.D., MPH - 2	Mehdi Mirsaeidi, M.D., MPH - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

Please list specific changes you intend to implement in your daily practice as a result of attending this activity. *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so. *

List topics related to this lecture that you want to learn more about?

Comments

Name

You are here

27th Annual South Miami Hospital Harry Kapp Symposium Evaluation